CSP - Certified Specialty Pharmacist Fulfillment and Dispensing Questions and Answers

Question 1

A specialty pharmacy receives a prescription for a temperature-sensitive biologic that must be maintained between 2°C and 8°C. The medication is being shipped overnight to a patient in a different state. Which of the following is the MOST critical component to ensure medication integrity upon arrival?

Accepted Answer

Including a temperature monitoring device in the package.

Answer

While all options are good practices, including a temperature monitoring device is the most critical component for ensuring and verifying the integrity of a cold chain shipment. This device provides a record of the temperature throughout transit, confirming whether any excursions outside the required 2°C to 8°C range occurred. This data is essential for determining if the medication is safe and effective to dispense to the patient upon arrival.

Question 2

A patient is prescribed a specialty medication that is part of a limited distribution network and also has a Risk Evaluation and Mitigation Strategy (REMS) program. What is the primary reason a manufacturer would implement these two restrictions concurrently?

Accepted Answer

To ensure enhanced safety monitoring and control over the dispensing process for a high-risk drug.

Answer

Manufacturers use limited distribution networks for drugs with complex handling, storage, or administration requirements. When a drug also carries a significant safety risk, an FDA-mandated REMS program is required to ensure the benefits outweigh the risks. Combining these two strategies allows the manufacturer to maintain tight control over the distribution, ensuring that only trained, certified pharmacies dispense the medication and that all safety protocols, such as patient monitoring and education, are strictly followed.

Question 3

A specialty pharmacist is dispensing a medication for which the patient's insurance has issued a prior authorization denial. The denial states 'step therapy requirements not met.' Which of the following is the most appropriate next step for the pharmacist to take?

Accepted Answer

Contact the prescriber to discuss the denial and assist in appealing or providing clinical rationale for the prescribed drug.

Answer

When a prior authorization is denied due to step therapy, it means the insurer requires the patient to try one or more preferred, often lower-cost, alternative medications first. The specialty pharmacist's role is to collaborate with the prescriber. This involves communicating the reason for denial and working with the prescriber's office to either submit an appeal with clinical justification for bypassing step therapy (e.g., contraindication, history of failure with the preferred agent) or to select an appropriate alternative.

Question 4

When dispensing a specialty medication that requires a Risk Evaluation and Mitigation Strategy (REMS) with Elements to Assure Safe Use (ETASU), which of the following is a mandatory action for the pharmacy?

Accepted Answer

Verify that the prescriber and pharmacy are certified in the REMS program before dispensing.

Answer

REMS programs with ETASU are designed for drugs with significant risks, and they include specific, required interventions beyond standard labeling. A common requirement is that healthcare providers who prescribe and pharmacies that dispense the medication must be specially certified. The dispensing pharmacy has a responsibility to verify its own certification and that of the prescriber before fulfilling the prescription to ensure all safety requirements are met.

Question 5

A patient is starting on a new injectable specialty medication that requires refrigeration. During the final dispensing check, the pharmacist is reviewing the contents of the shipment. In addition to the medication, ancillary supplies, and patient education materials, what other critical item should be included in the patient's first shipment?

Accepted Answer

A sharps container for proper needle disposal.

Answer

Patient safety is paramount in specialty pharmacy. When dispensing an injectable medication, it is the pharmacy's responsibility to provide the means for safe disposal of needles and syringes. Including a sharps container in the first shipment ensures the patient can immediately and properly dispose of biohazardous waste, preventing accidental needlesticks and protecting the community.

CSP - Certified Specialty Pharmacist Practice Test

CSP - Certified Specialty Pharmacist Practice Test

CSP - Certified Specialty Pharmacist Fulfillment and Dispensing Questions and Answers